|
Enlarge font
Reduce font
Protalix signs with Pfizer on Gaucher's disease drug
Protalix will make up to $115 million on the deal and retain 40% of future revenues.
Gali Weinreb1 Dec 09 13:55
For the whole article please click here.
|
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
feeds
HomeMarket prices | Site map | Newsletters | Israel links | About us | Support | Report Faults | Advertise | Archive | 
Home | News | Analysis | Features | Technology guide | Real estate | Israel in depth | International
Application delivery by 